5.29
price up icon4.13%   0.21
after-market アフターアワーズ: 5.61 0.32 +6.05%
loading
前日終値:
$5.08
開ける:
$5.1
24時間の取引高:
544.91K
Relative Volume:
2.66
時価総額:
$288.71M
収益:
$21.05M
当期純損益:
$-89.22M
株価収益率:
-1.8304
EPS:
-2.89
ネットキャッシュフロー:
$-64.50M
1週間 パフォーマンス:
+11.37%
1か月 パフォーマンス:
-3.99%
6か月 パフォーマンス:
-38.20%
1年 パフォーマンス:
+29.66%
1日の値動き範囲:
Value
$5.065
$5.98
1週間の範囲:
Value
$4.53
$5.98
52週間の値動き範囲:
Value
$3.73
$9.69

Tscan Therapeutics Inc Stock (TCRX) Company Profile

Name
名前
Tscan Therapeutics Inc
Name
セクター
Healthcare (1181)
Name
電話
857-399-9500
Name
住所
880 WINTER STREET, WALTHAM
Name
職員
188
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
TCRX's Discussions on Twitter

Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-16 開始されました BTIG Research Buy
2024-05-13 開始されました Needham Buy
2023-06-22 開始されました Wedbush Outperform

Tscan Therapeutics Inc (TCRX) 最新ニュース

pulisher
09:17 AM

TScan Therapeutics Announces Upcoming Oral Presentation of - GlobeNewswire

09:17 AM
pulisher
09:15 AM

TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition - StockTitan

09:15 AM
pulisher
04:52 AM

TScan Therapeutics' SWOT analysis: innovative therapy stock faces pivotal year - Investing.com India

04:52 AM
pulisher
Nov 04, 2024

Waltham cancer biotech adds to real estate footprint - The Business Journals

Nov 04, 2024
pulisher
Nov 04, 2024

TScan Therapeutics (NASDAQ:TCRX) Enters Second Amendment for Lease Agreement to Expand Operations at Winter Street FacilityOn October 28, 2024, TScan Therapeutics, Inc. finalized a second amendment to its lease agreement with PPF OFF 828-83 - Defense World

Nov 04, 2024
pulisher
Oct 26, 2024

Head to Head Review: ProKidney (NASDAQ:PROK) vs. TScan Therapeutics (NASDAQ:TCRX) - Defense World

Oct 26, 2024
pulisher
Oct 21, 2024

The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Oct 21, 2024
pulisher
Oct 18, 2024

Where are the Opportunities in (TCRX) - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 15, 2024

BTIG Initiates Coverage of TScan Therapeutics (TCRX) with Buy Recommendation - MSN

Oct 15, 2024
pulisher
Oct 08, 2024

Bank of Montreal Can Acquires Shares of 120,454 TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Bank of Montreal Can Invests $749,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Oct 08, 2024
pulisher
Oct 06, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Stock Position Lifted by Marshall Wace LLP - MarketBeat

Oct 06, 2024
pulisher
Oct 05, 2024

American Century Companies Inc. Increases Position in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

TCRXTScan Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 04, 2024
pulisher
Oct 04, 2024

TScan Therapeutics Announces Upcoming Presentations at the - GlobeNewswire

Oct 04, 2024
pulisher
Oct 04, 2024

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting - StockTitan

Oct 04, 2024
pulisher
Oct 04, 2024

Reviewing TScan Therapeutics (NASDAQ:TCRX) and Sorrento Therapeutics (OTCMKTS:SRNEQ) - Defense World

Oct 04, 2024
pulisher
Oct 01, 2024

Tscan Therapeutics Inc [TCRX] Stock bought by Insider Klencke Barbara for $26450.0 - Knox Daily

Oct 01, 2024
pulisher
Oct 01, 2024

Was there any good news for Tscan Therapeutics Inc (TCRX) stock in the last session? - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Market Momentum Report: Tscan Therapeutics Inc (TCRX)’s Negative Close at 4.98 - The Dwinnex

Oct 01, 2024
pulisher
Sep 30, 2024

TScan Therapeutics's SWOT analysis: biotech stock faces pivotal year - Investing.com

Sep 30, 2024
pulisher
Sep 28, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Sees Significant Growth in Short Interest - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

92,832 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Bought by Troluce Capital Advisors LLC - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Director Barbara Klencke Acquires 5,000 Shares - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

TScan therapeutics director buys $26,450 in company stock By Investing.com - Investing.com South Africa

Sep 24, 2024
pulisher
Sep 24, 2024

TScan therapeutics director buys $26,450 in company stock - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

940,831 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Purchased by Great Point Partners LLC - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Bank of New York Mellon Corp Purchases New Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Sep 23, 2024
pulisher
Sep 19, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares Sold by Marathon Trading Investment Management LLC - Defense World

Sep 19, 2024
pulisher
Sep 13, 2024

When the Price of (TCRX) Talks, People Listen - Stock Traders Daily

Sep 13, 2024
pulisher
Sep 05, 2024

TCRX Stock Sees Surge of Approximately 1.08% in Last Five Days - Knox Daily

Sep 05, 2024
pulisher
Sep 02, 2024

Can Tscan Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Sep 02, 2024
pulisher
Sep 02, 2024

Its Stock Has Paid Off Big Time For Tscan Therapeutics Inc - SETE News

Sep 02, 2024
pulisher
Aug 29, 2024

TScan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Aug 29, 2024
pulisher
Aug 29, 2024

TScan Therapeutics Director Acquires 18% More Stock - Simply Wall St

Aug 29, 2024
pulisher
Aug 28, 2024

How To Trade (TCRX) - Stock Traders Daily

Aug 28, 2024
pulisher
Aug 28, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Insider Zoran Zdraveski Sells 164,686 Shares of Stock - Defense World

Aug 28, 2024
pulisher
Aug 28, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Director Acquires $27,650.00 in Stock - MarketBeat

Aug 28, 2024
pulisher
Aug 28, 2024

TScan Therapeutics director buys $56,100 in company shares - Investing.com India

Aug 28, 2024
pulisher
Aug 27, 2024

TScan therapeutics executive sells over $950k in company stock By Investing.com - Investing.com Canada

Aug 27, 2024
pulisher
Aug 26, 2024

TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology (TCRX) - Seeking Alpha

Aug 26, 2024
pulisher
Aug 16, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) to Post FY2024 Earnings of ($1.07) Per Share, Lifesci Capital Forecasts - MarketBeat

Aug 16, 2024
pulisher
Aug 15, 2024

FY2024 Earnings Estimate for TScan Therapeutics, Inc. Issued By Lifesci Capital (NASDAQ:TCRX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

FY2024 EPS Estimates for TScan Therapeutics, Inc. Decreased by Analyst (NASDAQ:TCRX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

TScan Therapeutics, Inc. Forecasted to Earn Q3 2024 Earnings of ($0.31) Per Share (NASDAQ:TCRX) - Defense World

Aug 15, 2024
pulisher
Aug 14, 2024

TScan Therapeutics (NASDAQ:TCRX) Issues Quarterly Earnings Results - MarketBeat

Aug 14, 2024
pulisher
Aug 14, 2024

TScan Therapeutics (NASDAQ:TCRX) Receives Buy Rating from HC Wainwright - Defense World

Aug 14, 2024
pulisher
Aug 14, 2024

TScan Therapeutics (NASDAQ:TCRX) Rating Reiterated by Needham & Company LLC - Defense World

Aug 14, 2024
pulisher
Aug 13, 2024

TScan Therapeutics (NASDAQ:TCRX) Receives “Outperform” Rating from Wedbush - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts - Benzinga

Aug 13, 2024

Tscan Therapeutics Inc (TCRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):